Lipoprotein (a) levels and clinical decision-making: data from a Mexican cohort at a tertiary medical institution

Lipoprotein (a) levels and clinical decision-making: data from a Mexican cohort at a tertiary medical institution

Abstract Background and objective Approximately 20% of the global population has a Lp(a) concentrations above 50 mg/dL (> 125nmol/L), yet many remain unaware of the associated cardiovascular risks. In Mexico, routine measurement of Lp(a) is uncommon. This study aimed to investigate the frequency...

Full description

Saved in:
Bibliographic Details
Main Authors: Ivette Cruz-Bautista, Yuscely Flores-Jurado, Guillermo Roa-Álvarez, Mariana Salas-Aldana, Daniel Benjamin Elías-Lopez, Ricardo Federico Hernández-Franco, Sandra Rosales-Uvera, Arsenio Vargas-Vázquez, Raymundo Valdez-Echeverría, Sonia Luna del Villar Velasco, Liliana Muñoz-Hernández, Roopa Mehta, Mario Morales-Esponda, Misael Aguilar-Panduro, Guillermo Chan-Puga, Adrián Soto Mota, Carlos Alberto Aguilar-Salinas
Format: Article
Language:English
Published: BMC 2025-05-01
Series:Lipids in Health and Disease
Subjects:
Lp(a)
Awareness
Mexican cohort
Clinical interventions
Online Access:https://doi.org/10.1186/s12944-025-02610-w
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1186/s12944-025-02610-w

Similar Items